Ptc Therapeutics Inc. (PTCT): Camber Capital Management Adds 500,000 Shares to Its Position
Stephen DuBois' Camber Capital Management recently filed a Form 13G with the SEC, in which it reported raising its stake in Ptc Therapeutics Inc.
Posts Tagged ‘Stephen DuBois’
Carl Icahn Can’t Stop Buying Cheniere; Nelson Peltz Boosts Stake In SYSCO
Most individual investors already know the value of monitoring activist investors, who generally make value-enhancing proposals or push for changes at struggling companies in ...
Elite Hedge Funds’ Bullish Moves On These Four Stocks
The latest round of 13F filings kicked off at the beginning of October, but as these public filings are only required to be filed within 45 days of the end of each calendar quarter...
Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors
Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in three different healthcare...
Camber Capital Quick To Move On This Newly-Listed Biotech Stock
According to a recent filing with the Securities and Exchange Commission, Stephen DuBois's Camber Capital Management initiated a position in the newly-listed clinical-stage biopharmaceutical...
Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines Company (MDCO)
Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois.
Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over.
3 Stocks Hedge Funds Just Bought; Should You?
We have a trifecta of recent hedge fund buying activity for you to digest, featuring three different funds and three different stocks.
Masimo Corporation (MASI): Camber Capital Management Ups Passive Position to 5.5%
Stephen DuBois' Camber Capital Management has reported raising its passive position in Masimo Corporation (NASDAQ:MASI).
Cardica, Inc. (CRDC): Broadfin Capital Asks Other Shareholders to Support Its Crusade
Kevin Kotler’s Broadfin Capital doesn’t want to hear any more excuses from the Board of Cardica, Inc.
Universal American Corporation (UAM): Camber Capital Management Resumes Buying Shares
Stephen Dubois’ Camber Capital Management is again increasing its stakes in Universal American Corporation (NYSE:UAM).
Volcano Corporation (VOLC): Camber Capital Takes 9.81% Stake
Stephen Dubois’ Camber Capital Management has disclosed in a regulatory filing with Security and Exchange Commission a stake of 9.81% in medical equipment company Volcano Corporation...
Orthofix International NV (OFIX): Stephen Dubois Surges His Stake Amid Company’s Financial Statements Issues
As a new filing with the Securities and Exchange Commission showed, Camber Capital Management surged its exposure to Orthofix International NV (NASDAQ:OFIX).
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter Kolchinsky’s Latest Equity Moves
RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares.
Visium Asset Management Ups Passive CNMD Stake To Nearly 6%
Visium Asset Management, managed by Jacob Gottlieb, has boosted its stake in CONMED Corporation (NASDAQ:CNMD). In a new filing with the U.S.
Achillion Pharmaceuticals, Inc. (ACHN): Peter Kolchinsky’s RA Capital Sells Some More Shares
Peter Kolchinsky's RA Capital Management, in a new filing with the Securities and Exchange Commission, has disclosed the sale of around 1.70 million shares of Achillion Pharmaceuticals...
Cardica Inc. (CRDC): Broadfin Capital, Kevin Kotler Send Another Letter To The Board
In a recent filing with the Securities and Exchange Commission, Broadfin Capital has disclosed a letter sent to the Board of Directors of Cardica, Inc. (NASDAQ:CRDC).
Achillion Pharmaceuticals Inc. (ACHN): RA Capital Management Cuts Stake To 19.0% From 21.1%
RA Capital Management, led by Peter Kolchinsky, disclosed in a newly amended filing with the U.S.
Camber Capital Management Adds To Position In Genomic Health, Inc. (GHDX)
Stephen Dubois is optimistic about the prospects of Genomic Health, Inc. (NASDAQ:GHDX) and has increased his fund's holding of the stock.
Camber Capital Surges Stake In Sequenom Inc. (SQNM) To Over 5%
Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM).
Camber Capital Management Reveals New Position in Cardica, Inc. (CRDC)
Stephen Dubois' Camber Capital Management revealed a new stake in Cardica, Inc. (NASDAQ:CRDC).
Pay Attention to John Paulson’s Small Cap Stock Picks
John Paulson started his hedge fund, Paulson & Co., in 1994 using a merger arbitrage strategy.
5 Stocks Hedge Funds Bought Recently
Academic research on hedge funds have shown that the stocks bought by hedge funds outperform the market on average.
Five Hedge Fund Moves in Healthcare Sector From This Week
The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow.
Camber Capital Raises Exposure to CONMED Corporation (CNMD)
Stephen DuBois' Camber Capital has raised its holding in CONMED Corporation (NASDAQ:CNMD).
Stephen DuBois’s Hedge Fund Now Owns a Large Position in Ariad Pharmaceuticals
Stephen DuBois, Ariad Pharmaceuticals: In a new filing just reported to the SEC, Stephen DuBois's Camber Capital disclosed a new 5.4% stake in Ariad Pharmaceuticals, Inc. (...
Camber Capital Takes Big Position in Med-Tech Company Biolase
Camber Capital Management, a hedge fund managed by Stephen Dubois recently disclosed adding a new position to its equity portfolio, BIOLASE Inc (NASDAQ:BIOL).
CardioNet/BioTelemetry Cut By Benjamin J. Taylor’s Hedge Fund
CardioNet/BioTelemetry: CardioNet, Inc. is yet another company that has been recently downsized in the equity portfolio of a hedge fund.
Vanguard Health Systems, Inc. (VHS): Insiders Aren’t Crazy About It But Hedge Funds Love It
To the average investor, there are a multitude of gauges shareholders can use to monitor publicly traded companies.
Hedge Funds Aren’t Crazy About Given Imaging Ltd. (GIVN) Anymore
At the moment, there are plenty of methods shareholders can use to track stocks. Two of the most underrated are hedge fund and insider trading movement.
Is Cross Country Healthcare, Inc. (CCRN) Going to Burn These Hedge Funds?
If you were to ask many investors, hedge funds are viewed as useless, outdated investment vehicles of a forgotten age.
Masimo Corporation (MASI): Are Hedge Funds Right About This Stock?
At the moment, there are plenty of gauges market participants can use to monitor publicly traded companies.
Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
Hedge Funds Are Dumping Dendreon Corporation (DNDN)
To the average investor, there are tons of methods shareholders can use to monitor the equity markets.
Hedge Funds Are Betting On CONMED Corporation (CNMD)
If you were to ask many of your peers, hedge funds are seen as delayed, outdated financial vehicles of a period lost to current times.
Hedge Funds Aren’t Crazy About Volcano Corporation (VOLC) Anymore
If you were to ask many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age.
Hedge Funds Are Selling Universal American Corporation (UAM)
Now, according to many traders, hedge funds are perceived as delayed, outdated financial vehicles of an era lost to time.
Natus Medical Inc (BABY): Are Hedge Funds Right About This Stock?
If you were to ask many of your fellow readers, hedge funds are seen as useless, outdated financial vehicles of a period lost to current times.
Hedge Funds Are Betting On Wright Medical Group Inc (WMGI)
In the financial world, there are plenty of indicators investors can use to watch stocks. A pair of the most innovative are hedge fund and insider trading movement.
Is Amedisys Inc (AMED) Going to Burn These Hedge Funds?
In the eyes of many investors, hedge funds are seen as bloated, outdated financial vehicles of a period lost to current times.
Hologic, Inc. (HOLX): Are Hedge Funds Right About This Stock?
In the 21st century investor’s toolkit, there are many indicators market participants can use to watch stocks.
Is Quest Diagnostics Inc (DGX) Going to Burn These Hedge Funds?
To many of your fellow readers, hedge funds are assumed to be overrated, outdated investment tools of an era lost to time.
Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Hedge Funds Are Selling Humana Inc (HUM)
Humana Inc (NYSE:HUM) has made any of its supporters look smart for some time now. But nothing lasts forever.
A Smart Eli Lilly & Co. (LLY) Investor Does What Now?
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds' portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently.
Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Should You Buy Protalix BioTherapeutics Inc. (PLX)?
At the moment, there are many indicators shareholders can use to watch the equity markets. Two of the most innovative are hedge fund and insider trading activity.
Hedge Funds Are Crazy About Novavax, Inc. (NVAX)
To most shareholders, hedge funds are viewed as unimportant, old financial vehicles of years past.
Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.
